A critical evaluation of nalidixic acid in urinary-tract infections.
D004352:Drug Resistance, Microbial; D004755:Enterobacteriaceae / Q000187:drug effects; D006801:Humans; D066298:In Vitro Techniques; D009268:Nalidixic Acid / Q000009:adverse effects / Q000627:therapeutic use*; D011549:Pseudomonas / Q000187:drug effects; D014552:Urinary Tract Infections / Q000188:drug therapy* / Q000382:microbiology
D009268:Nalidixic Acid